Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years-Reference-Cited by-同舟云学术

Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years

Published:2011-04 Issue:4 Volume:53 Page:1148-1153
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fung James,Lai Ching-Lung,Yuen John,Cheng Charles,Wu Ringo,Ka-Ho Wong Danny,Seto Wai-Kay,Hung Ivan Fan-Ngai,Yuen Man-Fung

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24192/fullpdf

Reference20 articles.

1. Hepatitis B virus infection;Lee;N Engl J Med,1997

2. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004

3. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease;Yuen;Antivir Ther,2007

4. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy;Yuen;HEPATOLOGY,2001

5. Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB);Locarnini;J Hepatol,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entecavir-based combination therapies for chronic hepatitis B;Medicine;2018-12

2. Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK activation in HBV transgenic mice;Molecular Medicine Reports;2018-09-14

3. Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy;BMC Gastroenterology;2017-12

4. Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial;BMC Gastroenterology;2017-01-19

5. Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA;Yonsei Medical Journal;2017